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Abstract  
 
Background: The aetiology of dental caries is multifactorial and all contributing factors have been studied extensively. 
Streptococcus mutans (S. mutans) has been implicated as a primary odontopathogen and is an important target in caries 
prevention and management. Bacteriophage therapy is an antibacterial therapy that has garnered interest in human and 
veterinary medicine due to its numerous advantages. Bacteriophages are more numerous than bacteria and are highly 
specific and may be used to target S. mutans without disturbing the remaining oral flora. Aim: The purpose of this study 
was to isolate S. mutans from dental plaque and to attempt to isolate S. mutans-specific bacteriophages from the same 
material. Methodology: Plaque samples were obtained from patients using sterile swabs with transport medium. Samples 
were serially diluted and plated on TYCSB selective media. Suspect colonies (based on morphological appearance) were 
subjected to biochemical tests (catalase test and Gram staining). The presumptive identity of isolated bacterial colonies as 
S. mutans was confirmed molecularly (PCR, followed by electrophoresis). A filtrate prepared from dental plaque samples 
was used in spot assays against the S. mutans isolates to screen for presence of bacteriophages having lytic activity 
against them. Results: Seven isolates of S. mutans were obtained and a single bacteriophage having lytic activity against 
one of these isolates was recovered from the dental plaque filtrate; host-range studies indicated that the bacteriophage had 
a narrow range of activity (within the samples tested). Conclusion: This study has indicated that it is possible to isolate 
bacteriophages specific to S. mutans from the oral cavity. Further work is required to prepare an effective mix of 
bacteriophages that are suitable for targeting cariogenic bacteria within a plaque biofilm and potentially, these 
bacteriophages could be incorporated into future caries-management programmes.  
Keywords: Streptococcus mutans, bacteriophage, phage therapy, dental caries, dental plaque, caries prevention. 
Copyright @ 2020: This is an open-access article distributed under the terms of the Creative Commons Attribution license which permits unrestricted 
use, distribution, and reproduction in any medium for non-commercial use (NonCommercial, or CC-BY-NC) provided the original author and source 
are credited. 
 
INTRODUCTION  
Dental caries remain a highly prevalent disease 
in the human population in spite of its easily 
preventable nature. The aetiology of dental caries is 
multifactorial and all factors involved in its 
development have been studied extensively, including 
the role of various microorganisms.  
 
The oral microbiome consists of a diverse 
range of bacteria, viruses and fungi. Ecological 
imbalances favouring the growth of cariogenic bacteria 
and causing metabolic disharmony can lead to the 
development of dental decay [1], with Streptococcus 
mutans (S. mutans) implicated as a primary 
odontopathogen and important marker of caries [2, 3]. 
Hence, S. mutans is a prime target in caries prevention 
and management. S. mutans are gram-positive, non-
motile cocci. They show extraordinary ability to survive 
and flourish in a low pH environment and have an 
extensive range of genes for carbohydrate uptake and 
metabolism [4]. S. mutans’ virulence factors include 
production of extracellular polysaccharides, glucose-
dependent and glucose independent adhesion and 
contribution towards biofilm formation. Biofilms shows 
increased resistance to external and internal stresses and 
existence in biofilms can further influence growth rate, 
quorum sensing and gene expression of S. mutans [5]. 
S. mutans are also capable of producing bacteriocins 
known as mutacins against other bacteria [5, 6]. All 
these factors aid in the growth, survival and persistence 
of S. mutans [7].  
 
Traditional caries preventive strategies such as 
oral hygiene measures and diet modification 
indiscriminately target commensals such as 
Streptococcus spp., Actinomyces and Veillonella along 
with odontopathogens such as S. mutans and can create 
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open, non-competitive surfaces for pathogens to 
recolonize the oral cavity [8]. Various approaches 
eliminating or diminishing the cariogenic potential of S. 
mutans have been tested experimentally and reported in 
literature. Some of the most notable ones are the use of 
probiotics [9], bacterial replacement therapy [10], 
antimicrobial peptides [11], immunisation [12], 
interference with quorum sensing [7] and bacteriophage 
therapy [13].  
 
Bacteriophages are self-replicating viruses that 
specifically infect bacteria and are usually isolated from 
the same environment as their host. Depending on the 
type, bacteriophages may reproduce by lytic or 
lysogenic cycles or both [14]. Bacteriophages are highly 
specific and infect single or very few bacterial strains. 
They tend to be more numerous than bacteria and can 
also mutate more rapidly. Bacteriophage therapy is a 
treatment approach that utilises bacteriophages to 
combat infections by aiming to lower the bacterial load. 
Lytic phages are most commonly exploited as they 
destroy the bacterial host when they reproduce as 
opposed to lysogenic phages which do not kill the cells 
they infect. Bacteriophages may be delivered topically 
or orally. Thus far, phage therapy has not been 
associated with any major side effects. They are 
inherently non-toxic, demonstrate lack of cross-
resistance with antibiotics and due to their limited host 
range, reduce the potential for development of 
resistance [15]. Production of phages is becoming 
increasingly economical with technological 
advancements and may be equivalently priced if not 
cheaper than development of new antibiotics [15, 13].  
 
Bacteriophages have successfully been used 
for the treatment of various local and systemic 
infections in humans such as the management of 
antibiotic-resistant septicaemia [16, 17]. Studies have 
also been undertaken to assess the potential of 
bacteriophages in the management of dental infections 
such as periodontitis. In vitro studies have evaluated the 
effect of bacteriophages on endodontic [18] and 
periodontal [19, 20] pathogens and 47 some of these 
studies have shown promising results. However, studies 
investigating the role of bacteriophage therapy on 
cariogenic activity are fewer in number. The use of this 
approach in management of caries warrants interest as 
phages are target specific and unlikely to affect other 
oral flora. To date, three S. mutans phages have been 
isolated from saliva and their genomes sequenced [21, 
22, 1]. Other similar studies [23, 24] failed to yield any 
S. mutans- specific phages. This study aims to isolate S. 
mutans and detect its specific phage from dental plaque.  
 
MATERIALS AND METHODS  
Human subject enrolment: Ethical approval 
was obtained from The East of Scotland Ethics Service, 
IRAS ref. nos. 195501 REC Ref: 16/ES/0124 and 
information leaflets were sent out to patients selected on 
the basis of convenience sampling. Written consent was 
obtained from patients at the Edinburgh Dental 
Institute, Scotland on the day of sample collection. 
Participants were above 18 years of age, free of any 
serious systemic illness and showed clinical or 
radiographic signs of dental decay. Individuals 
undertaking a course of antibiotics were excluded. A 
total of thirty-nine samples were collected between 
February and March 2017.  
 
Sample collection and processing: Plaque 
samples were collected using ESwabTM Liquid Amies 
Collection and Transport System (catalogue no. 481CE; 
Copan Italia, Italy) and processed on the day of 
collection (within 3 hours). Each swab consisted of a 
sterile, flocked nylon fibre swab tip in 1 ml of liquid 
Amies transport medium. The samples were centrifuged 
at 8000xg for 3 min using the Fisherbrand
TM
 Mini 
Vortex Mixer (Fisher Scientific, Leicestershire, UK) to 
allow complete elution of the dental plaque into the 
liquid. 0.1 ml was used for bacterial isolation (as below) 
and the remainder of the sample was filtered through 
0.45 μm filter (Gilson®) and filtrates from each day of 
sampling were pooled together and stored at 4
O
 C.  
 
Bacterial isolation: Direct streaking and 
spread plating techniques were utilised. Plaque samples 
were serially diluted in distilled water (undiluted, 10
-1
, 
10
-2
, 10
-3
, 10
-4
, 10
-5
, and 10
-6
) and plated onto selective 
medium, Tryptone-Yeast extract-Cysteine-Sucrose-
Bacitracin agar (TYCSB) in order to isolate S. mutans. 
The culture medium was prepared using 0.2g L- cystine 
HCl monohydrate (Sigma Ultra), 15g bacteriological 
peptone (Oxoid), 5g yeast extract (Oxoid), 0.1g Sodium 
sulphite (Sigma), 0.1g Sodium chloride (Fisher), 1.0g 
Sodium phosphate (Sigma), 2.0g Sodium hydrogen 
carbonate (Fisher), 20g Sodium acetate (GPR) 20% w/v 
sucrose (Sigma), 15g granulated agar (Oxoid), 0.1 U/ml 
bacitracin (Sigma), distilled water. TYCSB culture 
medium was selected as it demonstrates high selectivity 
for mutans Streptococcci as compared to non-mutans 
bacteria. Additionally, highest rates of S. mutans 
recovery are associated with it as compared to other 
media [25].  
 
Brain Heart Infusion (BHI) agar, prepared 
from Brain Heart Infusion dehydrated powder, is a rich 
non-selective culture medium and samples were 
cultured on it in addition to TYCSB to boost the growth 
of any S. mutans present. Comparison of bacterial 
growth on both media ensured complete recovery of S. 
mutans from all samples. Plates were incubated at 37
O
C 
for 48 hours. Typed strain of S. mutans (20523 
Streptococcus mutans) was used as standard for 
morphological comparison. Suspect colonies were sub-
cultured until a pure form was obtained by repeated re-
plating. The colonies were subjected to biochemical 
tests including catalase test and Gram staining. Catalase 
test was performed by adding a small amount of 
bacterial culture onto a glass slide with a few drops of 
hydrogen peroxide. Production of bubbles indicated a 
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positive result. Colonies responding negatively to 
catalase test were subjected to Gram staining. Finally, 
molecular testing was carried out to confirm the identity 
as S. mutans using colony PCR with primers specific 
for amplification of the gtf B gene.  
 
Isolation of bacteriophage: Spot assays were 
carried out to determine the presence of bacteriophages. 
Bacterial lawn growth was obtained by adding 50 μL 
1M Magnesium Chloride (MgCl2), 50 μL 1M Calcium 
Chloride (CaCl2) to 3 mL of soft BHI overlay agar 
(0.7% agar) along with 200 μL of overnight cultures of 
S. mutans strains from Table 1. The mixture was poured 
over BHI agar plate and allowed to set. Pooled filtrates 
i.e. phage lysates, derived from dental plaque samples 
(Table 2) were used in spot assays. 10 μL of the phage 
lysate was spotted on the plates and these were 
incubated for 24 hours at 37
O
 C. Negative controls were 
set up for each spot assay.  
 
Series of enrichments of the filtrates with a 
combination of bacteria was carried out to boost any 
phages present. The enriched filtrates were also used in 
spot assays against the same bacterial hosts. Clear zones 
of lysis on the bacterial lawn were indicative of phage 
presence.  
 
Phage quantification: Plaque assays were 
carried out using the filtrate and host showing positive 
results in the spot assays. This was done to confirm the 
presence of phage as noted by spot assays and to 
quantify the level of phage available in the filtrate. 1:10 
serial dilutions were made for the enriched dental 
plaque filtrate. 100μL of the filtrate at each dilution was 
added to BHI broth along with 50 μL 1M MgCl2, 50 μL 
1M CaCl2 and 0.5 mL glycine. The mixture was poured 
over BHI agar plate and then incubated for 24 hours at 
37
O
 C. A negative control without any filtrate was also 
set up.  
 
RESULTS  
S. mutans isolation and strain collection  
Thirty-nine dental plaque samples were 
collected in total. Two samples were excluded due to 
duplication of subjects. All samples were used for 
bacteriophage filtrate assays (see below) and 
microbiological assessment was carried out on 13 
samples, with the aim of isolating S. mutans. Wan et al. 
[25] have described the colony morphology of S. 
mutans on TYCSB agar as tiny white colonies within a 
clear zone. Typed strain of S. mutans grown on TYCSB 
selective media was used as a positive control. Wild-
type colonies that showed a similar  grainy  
crystalline‘appearance to the typed strain (Figure 1 A) 
were considered to be putative S. mutans and were 
subjected to biochemical analysis. If more than one 
colony morphology was observed from a sample 
culture, both colony types were tested and treated as 
separate isolates. S. mutans are catalase negative 
bacteria and colonies testing negative in this test were 
Gram stained for further identification. S. mutans are 
described as Gram positive cocci organised in chains 
[26], thus Gram positive colonies (i.e. those stained 
violet when viewed microscopically; Figure 1B) were 
selected for molecular analysis to allow final 
identification. Thirty heterogeneous isolates were 
obtained from the culture of the plaque samples in total 
and these were all analysed as described above. Of 
these, seven isolates were positively identified as S. 
mutans following molecular analysis (Table 1).  
 
 
Fig-1: Appearance of S. mutans on: A: TYCSB culture medium B: Gram staining 
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Table-1: ‘Wild-type’ S. mutans isolated from dental plaque 
Sample 
ID 
Colony morphology Catalase 
test 
Gram 
Test 
PCR 
identification 
Isolate 
SO1 Very small, grainy colony, translucent- white 
colour 
- + + SO113021701 
SO1 Small, granular, white colony - + + SO113021702 
SO2 Medium sized, granular translucent- white 
colony 
- + + SO213021701 
SO9 Small, crystalline, golden-brown colony with a 
clear halo around it 
- + + SO903031701 
SO9 Small, white, crystal-like colony with a clear 
halo around it 
- + + SO0903031702 
S10 large, white, crystal-like colony - + + S1003031701 
S39 very small translucent-white crystalline colony - + + S3909021701 
 
Spot Assays and Phage isolation  
Spot assays were carried out to screen for the 
presence of phages. The negative control plates 
primarily showed good bacterial lawn growth. Pooled 
dental plaque filtrates and their enrichments were 
utilised (Table 2) against the bacteria isolated (listed in 
Table 1). All original filtrates yielded negative results in 
spot assays. Subsequently a series of enrichments were 
carried out for the filtrates and spot assays repeated.  
 
Evidence of lysis was noted in spot assays 
against S. mutans SO213021701 for the second round 
of enrichment on Filtrate 1, as demonstrated by clearing 
of the bacterial lawn in the region of filtrate application 
with denser, centrally located, clear plaques (Figure 2). 
The same enriched filtrate showed no activity against 
the other wild-type S. mutans isolates and no 
bacteriophage activity was detected with any of the 
other filtrates or enrichments.  
 
Table-2: Dental plaque filtrates used in phage isolation 
Sample ID Filtrate ID Number of enrichments carried out 
1-3 1 2 
4-7 2 3 
8-12 (excluding 11) 3 2 
13-27 4 1 
28-34 5 1 
36-38 6 - 
39 7 2 
 
 
Fig-2: Spot assay (using S. mutans SO213021701 and 2nd round of enrichment on Filtrate 1) indicating clearing of bacterial lawn at site of 
filtrate spotting with multiple, circular clear plaques centrally located (arrow) 
 
Plaque Assay  
Filtrate 1- enrichment 2 showing activity in the 
spot assay was diluted 1:10 and plaque assays carried 
out, demonstrating a clear titration effect of the distinct, 
round, homogenous plaques in the bacterial lawn 
(Figure 3), from which a titre of 1.27 x 10
7
 PFU/mL 
was calculated (from the 10
-4
 dilution).  
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Fig-3: Plaque assays indicating a clear dilution effect. At dilutions: A: 10-1, B: 10-2,   C: 10-3, D: 10-4, E: 10-5, F: 10-6 using S. mutans 
SO213021701 for the 2nd round of enrichment on Filtrate 1 
 
DISCUSSION  
S. mutans is considered to be the principal 
pathogen in the development of dental caries and 
consequently remains the chief target in many novel 
caries preventive approaches.  
 
Bacteriophage therapy has successfully been 
initiated in humans to manage various infections [27, 
16]. Utilising this approach in management of caries 
has also garnered interest in recent times. The oral 
cavity has been a source of numerous bacteriophages 
active against various bacteria, however only three 
bacteriophages with activity against S. mutans have 
been reported in literature. These include M102 [21], 
M102AD [22] and ɸAPCM01 [1]; all of which 
presented with a closely related genome.  
 
In contrast to previous studies, wild-type 
strains of S. mutans were isolated from dental plaque of 
individuals instead of using typed strains available from 
laboratories. Laboratory strains are cultured under 
optimal conditions and may lack various specific 
characteristics that are acquired by microorganisms in a 
complex ecological setting such as the oral cavity [28]. 
As a result the bacteria may behave differently and in 
order to avoid this discrepancy wild strains were 
obtained and purified. TYCSB culture medium was 
used due to its exemplary sensitivity and selectiveness 
for isolation of S. mutans. As previously mentioned 
TYCSB medium gives the highest recovery rates of S. 
mutans and inhibits growth of non-mutans Streptococci 
to a greater extent as compared to other selective 
culture media. It also allows identification of S. mutans 
based on a characteristic morphological appearance 
[25].  
 
In opposition to previous studies on the 
subject, our strategy was isolation from dental plaque 
instead of saliva. Collection of plaque using a swab 
offers an easier, time efficient and perhaps more 
effective sample collection. There has been limited 
success in isolation of S. mutans specific bacteriophages 
from the oral cavity in the past. Our study was 
successful in identifying a phage from only thirty-nine 
samples. This can perhaps be attributed due to dental 
biofilm collection instead of saliva.  
 
The bacteriophage isolated demonstrated an 
extremely limited host range but this reflects the 
inherent property of phages and is consistent with the 
observations reported in literature. This has traditionally 
been overcome by using a cocktail of phages to broaden 
the coverage of the target pathogen [29].The present 
study can be furthered by determining the genome 
sequence of the isolated bacteriophage to allow its 
complete identification and classification. The effect of 
the bacteriophage on S. mutans strains individually as 
well as a part of a biofilm model should also be 
assessed.  
 
In a time when resistance to antibiotics is a 
growing concern, therapeutic use of bacteriophages 
offers a suitable alternative. With further research 
bacteriophage therapy could perhaps be integrated into 
the management of dental caries.  
 
ACKNOWLEDGEMENTS  
This study was run jointly by the University of 
Edinburgh, NHS Lothian and Edinburgh Napier 
University. Partial funding was obtained from NHS 
endowment fund and Edinburgh Napier University. 
 
REFERENCES 
1. Dalmasso, M., De Haas, E., Neve, H., Strain, R., 
Cousin, F. J., Stockdale, S. R., & Hill, C. (2015). 
Isolation of a novel phage with activity against 
Streptococcus mutans biofilms. PLoS One, 10(9), 
e0138651.  
2. Russell, R. R. B. (2008). How has genomics altered 
our view of caries microbiology?. Caries 
research, 42(5), 319-327.  
3. Russell, R. R. (2009). Changing concepts in caries 
microbiology. American journal of dentistry, 22(5), 
304.  
  
Nazish Munir Mohamedhussein & J I Foley; Saudi J Oral Dent Res, Jan 2020; 5(1): 56-61 
© 2020 |Published by Scholars Middle East Publishers, Dubai, United Arab Emirates  61 
 
 
4. Bradshaw, D. J., & Lynch, R. J. (2013). Diet and 
the microbial aetiology of dental caries: new 
paradigms. International dental journal, 63, 64-72.  
5. Banas, J. A. (2004). Virulence properties of 
Streptococcus mutans. Front Biosci, 9(10), 1267-
77.  
6. Krzyściak, W., Jurczak, A., Kościelniak, D., 
Bystrowska, B., & Skalniak, A. (2014). The 
virulence of Streptococcus mutans and the ability 
to form biofilms. European Journal of Clinical 
Microbiology & Infectious Diseases, 33(4), 499-
515.  
7. Senadheera, D., & Cvitkovitch, D. G. (2008). 
Quorum sensing and biofilm formation by 
Streptococcus mutans. In Bacterial Signal 
Transduction: Networks and Drug Targets (pp. 
178-188). Springer, New York, NY.  
8. He, X. S., & Shi, W. Y. (2009). Oral microbiology: 
past, present and future. International journal of 
oral science, 1(2), 47.  
9. Anusha, R. L., Umar, D., Basheer, B., & Baroudi, 
K. (2015). The magic of magic bugs in oral cavity: 
Probiotics. Journal of advanced pharmaceutical 
technology & research, 6(2), 43.  
10. Pan, W., Mao, T., Xu, Q. A., Shao, J., Liu, C., & 
Fan, M. (2013). A new gcrR-deficient 
Streptococcus mutans mutant for replacement 
therapy of dental caries. The Scientific World 
Journal, 2013.  
11. Ren, Z., Cui, T., Zeng, J., Chen, L., Zhang, W., Xu, 
X., ... & Li, Y. (2016). Molecule targeting 
glucosyltransferase inhibits Streptococcus mutans 
biofilm formation and virulence. Antimicrobial 
agents and chemotherapy, 60(1), 126-135.  
12. Gambhir, R. S., Singh, S., Singh, G., Singh, R., 
Nanda, T., & Kakar, H. (2012). Vaccine against 
dental caries-an urgent need. J Vaccines 
Vaccin, 3(2), 136.  
13. Bhardwaj, S. B. (2014). Bacteriophage Therapy: A 
possible new alternative for oral diseases. Int. J. 
Curr. Microbiol. App. Sci, 3(6), 437-442.  
14. Goodridge, L. A. W. R. E. N. C. E., & Abedon, S. 
T. (2003). Bacteriophage biocontrol and 
bioprocessing: application of phage therapy to 
industry. SIM news, 53(6), 254-262.  
15. Loc-Carrillo, C., & Abedon, S. T. (2011). Pros and 
cons of phage therapy. Bacteriophage, 1(2), 111-
114.  
16. Weber-Dabrowska, B., Mulczyk, M., & Górski, A. 
(2003). Bacteriophages as an efficient therapy for 
antibiotic-resistant septicemia in man. 
In Transplantation proceedings (Vol. 4, No. 35, pp. 
1385-1386).  
17. Weber-Dąbrowska, B., Jończyk-Matysiak, E., 
Żaczek, M., Łobocka, M., Łusiak-Szelachowska, 
M., & Górski, A. (2016). Bacteriophage 
procurement for therapeutic purposes. Frontiers in 
microbiology, 7, 1177.  
18. Paisano, A. F., Spira, B., Cai, S., & Bombana, A. 
C. (2004). In vitro antimicrobial effect of 
bacteriophages on human dentin infected with 
Enterococcus faecalis ATCC 29212. Oral 
microbiology and immunology, 19(5), 327-330. 
19. Machuca, P., Daille, L., Vinés, E., Berrocal, L., & 
Bittner, M. (2010). Isolation of a novel 
bacteriophage specific for the periodontal pathogen 
Fusobacterium nucleatum. Appl. Environ. 
Microbiol., 76(21), 7243-7250.  
20. Phee, A., Bondy-Denomy, J., Kishen, A., Basrani, 
B., Azarpazhooh, A., & Maxwell, K. (2013). 
Efficacy of bacteriophage treatment on 
Pseudomonas aeruginosa biofilms. Journal of 
endodontics, 39(3), 364-369.  
21. Van der Ploeg, J. R. (2009). Analysis of CRISPR in 
Streptococcus mutans suggests frequent occurrence 
of acquired immunity against infection by M102-
like bacteriophages. Microbiology, 155(6), 1966-
1976.  
22. Delisle, A. L., Guo, M., Chalmers, N. I., Barcak, G. 
J., Rousseau, G. M., & Moineau, S. (2012). 
Biology and genome sequence of Streptococcus 
mutans phage M102AD. Appl. Environ. 
Microbiol., 78(7), 2264-2271.  
23. Hitch, G., Pratten, J., & Taylor, P. W. (2004). 
Isolation of bacteriophages from the oral 
cavity. Letters in applied microbiology, 39(2), 215-
219.  
24. Bachrach, G., Leizerovici‐Zigmond, M., Zlotkin, 
A., Naor, R., & Steinberg, D. (2003). 
Bacteriophage isolation from human saliva. Letters 
in Applied Microbiology, 36(1), 50-53.  
25. Wan, A. K. L., Seow, W. K., Walsh, L. J., & Bird, 
P. S. (2002). Comparison of five selective media 
for the growth and enumeration of Streptococcus 
mutans. Australian dental journal, 47(1), 21-26.  
26. Facklam, R. (2002). What happened to the 
streptococci: overview of taxonomic and 
nomenclature changes. Clinical microbiology 
reviews, 15(4), 613-630.  
27. Weber-Dabrowska, B., Mulczyk, M., & Górski, A. 
(2001). Bacteriophage therapy for infections in 
cancer patients. Clinical and Applied Immunology 
Reviews, 1(3-4), 131-134.  
28. Palková, Z. (2004). Multicellular microorganisms: 
laboratory versus nature. EMBO reports, 5(5), 470-
476.  
29. Lu, T. K., & Koeris, M. S. (2011). The next 
generation of bacteriophage therapy. Current 
opinion in microbiology, 14(5), 524-531. 
 
